Has Susan Roux, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $2,053 in general payments to Susan Roux, APRN across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Roux, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Roux, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Roux, APRN

Psychiatric/Mental Health · Tampa, FLNPI 1366613309

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 71 payments — averaging $28.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$704
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$304
Supernus Pharmaceuticals, Inc.$209
E.r. Squibb & Sons, L.L.C.$147
Axsome Therapeutics, Inc.$140
Corium, LLC$133
plus $416 from 10 others

What the payments were for

Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	29	$704
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$304
Supernus Pharmaceuticals, Inc.	7	$209
E.r. Squibb & Sons, L.L.C.	2	$147
Axsome Therapeutics, Inc.	2	$140
Corium, LLC	2	$133
Sunovion Pharmaceuticals Inc.	7	$90
Otsuka America Pharmaceutical, Inc.	4	$67
Johnson & Johnson	4	$63
Takeda Pharmaceuticals U.S.A., Inc.	3	$59
Alkermes, Inc.	2	$40
Bausch Health US, LLC	1	$24
Neurocrine Biosciences, Inc.	1	$23
Vanda Pharmaceuticals Inc.	1	$18
Teva Pharmaceuticals USA, Inc.	1	$18
Neos Therapeutics, LP	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,053 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Medicare billing

Part B allowed, 2024

$17,597

Medicare patients

Services billed

300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CaplytaLumateperone Tosylate	30	$49,736
RexultiBrexpiprazole	12	$17,756
VraylarCariprazine Hcl	14	$10,229
VyvanseLisdexamfetamine Dimesylate	11	$4,344
Aripiprazole	94	$3,623
Citalopram HbrCitalopram Hydrobromide	33	$3,266
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	44	$2,368
Quetiapine Fumarate	132	$2,285
Oxcarbazepine	40	$1,838
Buspirone Hcl	139	$1,800
Propranolol Hcl	88	$1,715
Trazodone Hcl	218	$1,295
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	37	$1,192
Hydroxyzine Hcl	52	$1,189
Prazosin Hcl	25	$1,072

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$304	$49,73630 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$67	$17,75612 claims
AbbVieVraylar	$704	$10,22914 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse	$59	$4,34411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Tampa

Cheedy JajaTampa$266K
Tonya King-CharltonTampa$31K
Michele CreamerTampa$18K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →